The multifaceted nature of ovarian cancer has severely hampered the development of effective therapeutics
over the years. The complicate nature of ovarian cancer makes it therapeutically challenging, therefore,
there has been a renewed interest in phytochemistry. Phytochemicals have emerged as a potential therapeutic
option due to less side effects. Moreover, the signaling inhibition properties have also been studied extensively
in recent times. A growing number of data obtained via high-throughput technologies has started to delineate
the complex oncogenic signaling networks, thus broadening the therapeutic opportunities. Within the network,
microRNAs (miRNAs) have been shown to play a versatile role in the regulation of cancer. Quercetin has been
in the spotlight over the years because of its high pharmacological values and substantial evidence has demonstrated
its anti-proliferative effect against various types of cancers. Despite the versatility of quercetin, little is
known about its anti-proliferative potential towards ovarian cancer. This review sheds some light on quercetin
as an alternative therapeutic approach to cancer. Furthermore, we also addresss the interplay between miRNAs
and quercetin in the regulation of apoptosis in ovarian cancer.
Keywords: Quercetin, ovarian cancer, chemo-preventive agent, apoptosis, miRNAs, phytochemicals.
Rights & PermissionsPrintExport